tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

TNDM Stock Latest News

Tandem announces publication of results from trial of Control-IQ+ AID technology
The FlyTandem announces publication of results from trial of Control-IQ+ AID technology
20d ago
TNDM
Tandem Diabetes launches new Control-IQ+ technology
PremiumThe Fly
Tandem Diabetes launches new Control-IQ+ technology
21d ago
TNDM
Positive Outlook for Tandem Diabetes Care: Buy Rating Affirmed Amid Upcoming Trial Results
PremiumRatings
Positive Outlook for Tandem Diabetes Care: Buy Rating Affirmed Amid Upcoming Trial Results
21d ago
TNDM
Optimistic Buy Rating for Tandem Diabetes Care Amid Attractive Valuation and Growth Potential
PremiumRatings
Optimistic Buy Rating for Tandem Diabetes Care Amid Attractive Valuation and Growth Potential
26d ago
TNDM
Tandem Diabetes COO buys $191K in common stock
PremiumThe Fly
Tandem Diabetes COO buys $191K in common stock
28d ago
TNDM
Tandem Diabetes Care: A Buy Rating Backed by Growth Potential and Valuation Opportunity
PremiumRatingsTandem Diabetes Care: A Buy Rating Backed by Growth Potential and Valuation Opportunity
29d ago
TNDM
Tandem, Check Point, Chipotle, FTAI, AES: Trending by Analysts
Premium
Weekend Updates
Tandem, Check Point, Chipotle, FTAI, AES: Trending by Analysts
1M ago
AES
CMG
Royal Caribbean upgraded, AppLovin downgraded: Wall Street’s top analyst calls
Premium
The Fly
Royal Caribbean upgraded, AppLovin downgraded: Wall Street’s top analyst calls
1M ago
APP
GEV
Tandem Diabetes downgraded to Equal Weight from Overweight at Morgan Stanley
PremiumThe Fly
Tandem Diabetes downgraded to Equal Weight from Overweight at Morgan Stanley
1M ago
TNDM
Tandem Diabetes downgraded to Neutral from Buy at Citi
PremiumThe Fly
Tandem Diabetes downgraded to Neutral from Buy at Citi
1M ago
TNDM
Dollar General downgraded, Oracle upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Dollar General downgraded, Oracle upgraded: Wall Street’s top analyst calls
1M ago
DE
DG
Wells Fargo downgrades Tandem Diabetes on market share loss
PremiumThe Fly
Wells Fargo downgrades Tandem Diabetes on market share loss
1M ago
PODD
TNDM
Tandem Diabetes downgraded to Equal Weight from Overweight at Wells Fargo
PremiumThe FlyTandem Diabetes downgraded to Equal Weight from Overweight at Wells Fargo
1M ago
TNDM
Tandem Diabetes downgraded to Market Perform from Outperform at Bernstein
Premium
The Fly
Tandem Diabetes downgraded to Market Perform from Outperform at Bernstein
1M ago
TNDM
Tandem Diabetes price target lowered to $53 from $60 at Barclays
Premium
The Fly
Tandem Diabetes price target lowered to $53 from $60 at Barclays
1M ago
TNDM
Tandem Diabetes Care: Record Sales and Strategic Growth
PremiumCompany Announcements
Tandem Diabetes Care: Record Sales and Strategic Growth
1M ago
TNDM
Tandem Diabetes price target lowered to $55 from $65 at RBC Capital
PremiumThe Fly
Tandem Diabetes price target lowered to $55 from $65 at RBC Capital
1M ago
TNDM
Tandem Diabetes price target lowered to $33 from $37 at Baird
PremiumThe Fly
Tandem Diabetes price target lowered to $33 from $37 at Baird
1M ago
TNDM
Sell Rating for Tandem Diabetes Care Due to Revenue Shortfalls and High Valuation
PremiumRatings
Sell Rating for Tandem Diabetes Care Due to Revenue Shortfalls and High Valuation
1M ago
TNDM
Tandem Diabetes price target lowered to $58 from $63 at Canaccord
PremiumThe FlyTandem Diabetes price target lowered to $58 from $63 at Canaccord
1M ago
TNDM
Tandem Diabetes Care: FDA Approval and Strategic Growth Opportunities Drive Buy Rating
Premium
Ratings
Tandem Diabetes Care: FDA Approval and Strategic Growth Opportunities Drive Buy Rating
1M ago
TNDM
Tandem Diabetes Care Reports Record 2024 Sales Growth
Premium
Company Announcements
Tandem Diabetes Care Reports Record 2024 Sales Growth
1M ago
TNDM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >